Day: September 2, 2021

TORONTO and CHICAGO, Sept. 02, 2021 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP) (OTCQX: MEDXF) today announced that Ken d’Entremont, Chief Executive Officer of Medexus, and Marcel Konrad, Chief Financial Officer of Medexus, will be presenting at the H.C. Wainwright 23rd Annual Global Investment Conference being held virtually between September 13-15, 2021. Medexus’s presentation will be available on-demand to registered attendees via the conference platform beginning Monday, September 13, 2021, at 7:00 AM Eastern Time. The webcast can be accessed here and on the investor relation section of the Medexus website at https://www.medexus.com/en_US/investors. Management will be participating in one-on-one meetings with qualified members of the investor community throughout the conference. About...

This expanded use by SANDAG reinforces the US market reach of mdf commerce in the strategic sourcing sector. MONTREAL, Sept. 02, 2021 (GLOBE NEWSWIRE) — mdf commerce inc. (TSX:MDF), a leader in SaaS commerce technology solutions, announces today that the San Diego Association of Governments (SANDAG), a regional government agency that represents 18 cities and the County of San Diego, plans to expand its use of the platform to encompass its small and disadvantaged vendor program and its grant distribution program. In addition to the existing 10-year agreement with mdf commerce for its end-to-end contract lifecycle management (CLM) solution, SANDAG has implemented tailored features and functionality from the mdf commerce Strategic Sourcing suite and is using the certification and pre-qualification modules to manage its diversity and...

-Principal Investigator Dr. Craig McDonald Will Deliver Late-Breaking Oral Presentation, One of Only Three Selected by WMS- LOS ANGELES, Sept. 02, 2021 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR) (“Capricor” or “the Company”), a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of a broad spectrum of diseases, announced today that the Company will present final data from its HOPE-2 clinical trial with asset CAP-1002 at this year’s World Muscle Society Virtual Congress (WMS). HOPE-2 is Capricor’s randomized, double-blind, placebo-controlled, Phase II clinical trial in 20 patients with late-stage Duchenne muscular dystrophy (DMD), conducted at nine sites in the U.S. The late-breaking results will be presented in an oral session on Sept....

LONDON, Sept. 02, 2021 (GLOBE NEWSWIRE) — Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced that management will present at the following investor conferences in September.Wells Fargo Virtual Healthcare Conference on Friday, September 10, 2021 at 10:40am ET / 3:40pm UK H.C. Wainwright 23rd Annual Global Investment Conference available beginning Monday, September 13, 2021 at 7:00am ET / 12:00pm UK Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on Wednesday, September 22, 2021 at 8:15am ET / 1:15pm UKA live and archived webcast of the presentations will be available in the Events & Presentations section of the Achilles website. About Achilles TherapeuticsAchilles is a clinical-stage biopharmaceutical...

VANCOUVER, British Columbia, Sept. 02, 2021 (GLOBE NEWSWIRE) — Dear Shareholders, it has been a fast paced start for NevGold Corp. (“NevGold”) (TSXV:NAU), with a lot of positive progress since our first day of public trading on the TSXV on June 29, 2021. I write this update to shareholders very excited about what the future has in store as we enter into our first active field season with exploration and drilling at our Limousine Butte and Cedar Wash projects in Nevada. We are a new player in the gold space, fully funded, with advanced exploration and resource stage projects in both Nevada and British Columbia. Market UpdateAlthough it has been a quiet market period over July and August for many equities, including natural resources and other industries, we have performed well, trading consistently above our C$0.40 going public...

CARROLLTON, Texas, Sept. 02, 2021 (GLOBE NEWSWIRE) — ADDvantage Technologies Group, Inc. (NASDAQ: AEY) (“ADDvantage Technologies” or the “Company”) today announced that its Paycheck Protection Program (“PPP”) loan has been forgiven. In April 2020, the Company received funding from the Small Business Administration’s (“SBA”) Paycheck Protection Program in the amount of $2.9 million. The Company was notified by its primary lender that it has received 100% loan forgiveness from the SBA on the PPP loan. The loan forgiveness of $2.9 million will be recognized as a gain on debt extinguishment in the financial results for the fourth fiscal quarter, which is the period ending September 30, 2021. About ADDvantage Technologies Group, Inc. ADDvantage Technologies Group, Inc. (Nasdaq: AEY) is a communications infrastructure services and equipment...

F-Secure Corporation, Stock Exchange Release, 2 September 2021, at 15.00 EEST Nordea Funds’ voting rights in F-Secure have reached (10) per cent of the total voting rights F-Secure Corporation (“F-Secure”) has received an announcement from Nordea Funds Ltd (“Nordea Funds”) on 2 September 2021, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcement, the number of voting rights in F-Secure controlled by Nordea Funds reached ten (10) per cent of the total voting rights of F-Secure Corporation on 1 September 2021. Total position of Nordea Funds subject to the notification:  % of shares and voting rights % of shares and voting rights through financial instruments Total of both in % Total number of shares and voting rights...